key: cord-0762352-8itg6a2j
authors: Sahin, Mustafa; Akkus, Erman
title: Comment on “Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management”
date: 2020-09-25
journal: J Transl Int Med
DOI: 10.2478/jtim-2020-0030
sha: f5da3f6ed95451416045435856b27811438b5dcd
doc_id: 762352
cord_uid: 8itg6a2j

nan

We read interesting correspondence reported by Liu et al. [1] We would like to remind the forgotten aspects of ACE 2 enzyme. ACE 2 enzyme doesn't only hydrolyze angiotensin proteins, it also hydrolyzes ghrelin, Apelin-13 and other proteins. [2] ARB and ACEI may increase ACE2 enzyme, which may increase the infection and decrease apelin-13 and ghrelin levels.

Ghrelin and Apelin-13 are reported to be neuroprotective. [3, 4] Also, after ischemic injury, ghrelin seems to improve recovery. [4] In COVID patients, taking these drugs may be more prone to stroke and other neurological complications. Decrease in ghrelin levels may increase the virus induced acute lung injury. [5] Decreased level of these hormones may be responsible from several complications in COVID-19.

The other aspects of diseases and drugs that may effect ACE2 expression [1] is they may also effect the response of drugs targetting COVID-19. We don't know if vaccine efficiency may also be affected by these factors.

Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

The neuroprotective effect of apelin-13 in a mouse model of intracerebral hemorrhage

Temporospatial effects of acyl-ghrelin on activation of astrocytes after ischaemic brain injury

Ghrelin attenuates sepsis-induced acute lung injury by inhibiting the NF-κB, iNOS, and Akt signaling in alveolar macrophages

None declared.